Engaging specialist oncologists in the assessment of oncology drugs in Canada
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 2017
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents (MeSH)
- Canada (MeSH)
- Cooperative Behavior (MeSH)
- Drug Approval (MeSH)
- Drug Utilization Review (MeSH)
- Humans (MeSH)
- Interdisciplinary Communication (MeSH)
- Neoplasms (MeSH)
- Oncologists (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Specialization (MeSH)
- Treatment Outcome (MeSH)
published in
- The Lancet Oncology Journal